| Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis A Williams, GJ Hatch, SO Clark, KE Gooch, KA Hatch, GA Hall, K Huygen, ... Tuberculosis 85 (1-2), 29-38, 2005 | 208 | 2005 |
| Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity KA Ryan, KR Bewley, SA Fotheringham, GS Slack, P Brown, Y Hall, ... Nature communications 12 (1), 81, 2021 | 161 | 2021 |
| Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing SA Sharpe, H McShane, MJ Dennis, RJ Basaraba, F Gleeson, G Hall, ... Clinical and Vaccine Immunology 17 (8), 1170-1182, 2010 | 150 | 2010 |
| Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples K Lewandowski, Y Xu, ST Pullan, SF Lumley, D Foster, N Sanderson, ... Journal of clinical microbiology 58 (1), 10.1128/jcm. 00963-19, 2019 | 145 | 2019 |
| Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a … R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, M Clout, ... The Lancet 398 (10318), 2277-2287, 2021 | 131 | 2021 |
| Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques AD White, L Sibley, MJ Dennis, K Gooch, G Betts, N Edwards, ... Clinical and Vaccine Immunology 20 (5), 663-672, 2013 | 122 | 2013 |
| Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19 FJ Salguero, AD White, GS Slack, SA Fotheringham, KR Bewley, ... Nature Communications 12 (1), 1260, 2021 | 121 | 2021 |
| Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis SA Sharpe, E Eschelbach, RJ Basaraba, F Gleeson, GA Hall, A McIntyre, ... Tuberculosis 89 (6), 405-416, 2009 | 79 | 2009 |
| Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge J Vipond, R Vipond, E Allen-Vercoe, SO Clark, GJ Hatch, KE Gooch, ... Vaccine 24 (37-39), 6340-6350, 2006 | 49 | 2006 |
| mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection S Rauch, K Gooch, Y Hall, FJ Salguero, MJ Dennis, FV Gleeson, D Harris, ... Biorxiv, 2020.12. 23.424138, 2020 | 47 | 2020 |
| Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge KA Ryan, KR Bewley, SA Fotheringham, P Brown, Y Hall, AC Marriott, ... BioRxiv, 2020.05. 29.123810, 2020 | 42 | 2020 |
| Differences in monocyte: lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques L Sibley, K Gooch, A Wareham, S Gray, A Chancellor, S Dowall, S Bate, ... Scientific reports 9 (1), 3340, 2019 | 34 | 2019 |
| Heterosubtypic cross-protection correlates with cross-reactive interferon-gamma-secreting lymphocytes in the ferret model of influenza KE Gooch, AC Marriott, KA Ryan, P Yeates, GS Slack, PJ Brown, ... Scientific reports 9 (1), 2617, 2019 | 28 | 2019 |
| An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques SA Sharpe, AD White, L Sibley, F Gleeson, GA Hall, RJ Basaraba, ... PLoS One 12 (3), e0171906, 2017 | 28 | 2017 |
| Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung KA Ryan, GS Slack, AC Marriott, JA Kane, CJ Whittaker, NJ Silman, ... PloS one 13 (9), e0202675, 2018 | 27 | 2018 |
| Influenza A virus challenge models in cynomolgus macaques using the authentic inhaled aerosol and intra-nasal routes of infection AC Marriott, M Dennis, JA Kane, KE Gooch, G Hatch, S Sharpe, ... PLoS One 11 (6), e0157887, 2016 | 24 | 2016 |
| ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models T Lambe, AJ Spencer, KM Thomas, KE Gooch, S Thomas, AD White, ... Communications biology 4 (1), 915, 2021 | 20 | 2021 |
| Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques KR Bewley, K Gooch, KM Thomas, S Longet, N Wiblin, L Hunter, K Chan, ... Science advances 7 (37), eabg7996, 2021 | 19 | 2021 |
| One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model KE Gooch, TRF Smith, FJ Salguero, SA Fotheringham, RJ Watson, ... Vaccine 39 (34), 4885-4894, 2021 | 19 | 2021 |
| Influence of aerosol delivered BCG vaccination on immunological and disease parameters following SARS-CoV-2 challenge in rhesus macaques AD White, L Sibley, C Sarfas, AL Morrison, K Bewley, C Churchward, ... Frontiers in immunology 12, 801799, 2022 | 18 | 2022 |
